|
EP1649066A2
|
|
Multiplexed molecular beacon assay for detection of pathogens
|
|
US2005019556A1
|
|
Labeling and authentication of metal objects
|
|
US2004209376A1
|
|
Assemblies of differentiable segmented particles
|
|
WO2004076682A2
|
|
Targets for controlling cellular growth and for diagnostic methods
|
|
WO2004013303A2
|
|
Modified annexin proteins and methods for treating vaso-occlusive sickle-cell disease
|
|
US2004086515A1
|
|
Modified annexin proteins and methods for treating vaso-occlusive sickle-cell disease
|
|
WO03105561A2
|
|
Method and devices for diagnosing and treating choroid plexus failure
|
|
WO03097811A2
|
|
Cellular gene targets for controlling cell growth
|
|
WO03095978A2
|
|
Methods for time-alignment of liquid chromatography-mass spectrometry data
|
|
WO03086302A2
|
|
Propagermanium for treating myeloma bone disease and other bone disorders
|
|
US2003078703A1
|
|
Cytometry analysis system and method using database-driven network of cytometers
|
|
US2003111596A1
|
|
Mass spectrometric quantification of chemical mixture components
|
|
US2003078739A1
|
|
Feature list extraction from data sets such as spectra
|
|
US2003040123A1
|
|
Peak selection in multidimensional data
|
|
AU2002312610A1
|
|
Directed enzymatic modification of analytes for affinity capture and analysis
|
|
US2002197278A1
|
|
Covalent coupling of botulinum toxin with polyethylene glycol
|
|
WO02090381A1
|
|
Chemokine-binding proteins for treating congestive heart failure
|
|
AU2002307090A1
|
|
Methods and reagents for multiplexed analyte capture, surface array self-assembly, and analysis of complex biological samples
|
|
WO02077207A1
|
|
Cell-based assays for the simultaneous and discrete analysis of multiple analytes
|
|
AU2002252035A1
|
|
Modified annexin proteins and methods for preventing thrombosis
|
